Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 8, 2007

View Archived Issues

Avocado extract shows in vitro activity against skin fungal pathogens

New therapeutic agents for glaucoma disclosed in recent Aerie patent

Novel treatment options for hematological disorders disclosed in recent AstraZeneca and IRM patents

Recent patents cover novel therapeutic agents for cardiovascular disorders

AN-2728: a novel antipsoriatic profiled at Anacor

elbion and Wyeth team up on PDE10 inhibitors for CNS disorders

Avicena completes dose-escalating portion of chronic toxicology study of PD- 02

Transtec shown to be safe and effective for treatment of cancer pain

Kuros begins phase II bone regeneration study

GSK reports on new HCV RNA polymerase inhibitor

ACT-078573 shows improvement in sleep efficiency in primary insomnia

NXY-059 safe in acute cerebral hemorrhage: CHANT study results

Benefit seen in some ischemic stroke patients given ONO-2506

WP-760 displays selectivity against melanoma cells in vitro

Clinical data on vinflunine in metastatic breast cancer presented

Favorable data on the gemcitabine/Myocet combination from a phase II trial

Glufosfamide studied in new phase II trial for recurrent, sensitive SCLC

MitoQ begins phase II study to reduce liver damage in HCV patients

Direct thrombin inhibitor flovagatran set to enter registrational program

MultiCell makes progress toward phase IIb study of MCT-125 in MS

RX-10100 to be studied in NINDS Anticonvulsant Screening Program

Elacyt to be studied for metastatic colorectal cancer

Orion and Abbott continue discussions on phase III study of levosimendan

European orphan drug designation for Fodosine in CTCL

Genta to appeal Genasense non-approvable letter in CLL

Romidepsin studied with bortezomib for relapsed/refractory multiple myeloma

Pfizer to acquire BioRexis Pharmaceutical

European label extension sought for Evoltra for elderly patients with AML

Pro-Pharmaceuticals commences NDA filing for Davanat

Priority review for Lovenox sNDA in acute STEMI

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...